a
2023
De novo design of peptides that form transmembrane barrel pores killing antibiotic resistant bacteria
DEB, Rahul; Ivo KABELKA; Jan PŘIBYL and Robert VÁCHA
Basic information
Original name
De novo design of peptides that form transmembrane barrel pores killing antibiotic resistant bacteria
Name in Czech
De novo design peptidů, které tvoří transmembránové válcovité póry zabíjející bakterie odolné vůči antibiotikům
Authors
DEB, Rahul; Ivo KABELKA; Jan PŘIBYL and Robert VÁCHA
Edition
BPS Annual Meeting 2023, 2023
Other information
Type of outcome
Konferenční abstrakta
Country of publisher
United States of America
Confidentiality degree
is not subject to a state or trade secret
Marked to be transferred to RIV
Yes
RIV identification code
RIV/00216224:14740/23:00132296
Organization
Středoevropský technologický institut – Repository – Repository
Keywords (in Czech)
návrh antimikrobiálních peptidů; transmembránové nanopóry; mikroskopie atomárních sil, KryoEM
Keywords in English
antimicrobial peptide design; transmembrane nanopores; atomic force microscopy; CryoEM
Links
LM2018127, research and development project. LX22NPO5103, research and development project.
In the original language
De novo design of peptides that self-assemble into transmembrane barrel-like nanopores is challenging due to the complexity of several competing interactions involving peptides, lipids, water, and ions. We have develop a computational approach for the de novo design of α-helical peptides that self-assemble into stable transmembrane barrel pores with a central nano-sized functional channel. We formulate the previously missing design guidelines and report 52 sequence patterns that can be tuned for specific applications using the identified role of each residue. Atomic force microscopy, fluorescent dye leakage, and cryo-EM experiments confirm that the designed peptides form leaky membrane nanopores in vitro. Customized designed peptides act as antimicrobial agents able to kill even antibiotic-resistant ESKAPE bacteria at micromolar concentrations, while exhibiting low toxicity to human cells. The peptides and their assembled nanopore structures can be similarly fine-tuned for other medical and biotechnological applications.
Displayed: 2/5/2026 23:06